News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
69 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Teva’s Job Cuts Hit 208 Philadelphia Employees
The cuts are being made as the company grapples with a debt of between $30 and $35B and a restructuring of its R&D in order to combat dramatically declining revenue from its generic pipeline.
January 19, 2018
·
2 min read
·
Alex Keown
Business
Bay Area Biotech Perlara’s Rare Strategy for Getting Ahead: Telling the Truth
Perlstein’s approach with his start-up, Perlara, is radically different from how most start-ups operate.
January 19, 2018
·
1 min read
Pharm Country
Little Known Life Science Hedge Fund Dethroning Ackman’s Pershing Square
This little-known hedge fund that has a focus on biotech and the life sciences beat out a couple of the heavy-hitters, David Einhorn and Bill Ackman.
January 19, 2018
·
3 min read
·
Mark Terry
Deals
Why This Seattle Biotech Could be an M&A Target
Immune Design is a clinical-stage immunotherapy company.
January 19, 2018
·
3 min read
·
Mark Terry
Deals
Acorda Rumored to be Gaining Buyout Interest From Biogen, UCB and Other Suitors
All of the recent problems have caused the company’s largest shareholder to push for a sale.
January 19, 2018
·
2 min read
·
Mark Terry
Business
Shire’s Incoming Financial Head Honcho Finally Gets a Start Date
Shire will have its new CFO in March.
January 19, 2018
·
2 min read
·
Alex Keown
Job Trends
Why AstraZeneca’s New Drug Strategy Seems to be Bearing Fruit
Astra has seen a fourfold increase in research productivity following a narrowing of disease focus and cuts in laboratory and staff over the past seven years, Reuters reported Thursday.
January 19, 2018
·
2 min read
·
Alex Keown
Policy
Medtronic Snags Win in Overcharging Lawsuit, Defibrillator Case Fees
The medtech titan logged a series of legal wins this week.
January 19, 2018
·
1 min read
Business
This Cancer Drug Could Bring in $3.8B for AstraZeneca
The survey of 51 oncologists suggests broad uptake of Imfinzi in advanced lung cancer patients who can’t be treated with surgery.
January 19, 2018
·
1 min read
Deals
Get Ready for the M&A Explosion
A look at whether the new tax reform will really spur a M&A spending spree for drugmakers.
January 19, 2018
·
2 min read
·
Karl Thiel
1 of 7
Next
